Benitec Biopharma Limited (BNTC) Stock Price

15.86 ▼ -0.50 (-3.06%)
Open: 13.17 Vol: 409.22K Day's range: 13.09 - 16.31 Nov 03, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BNTC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 15.86▲ 15.99▼ 15.88▼ 16.15▼ 15.86▼
MA10 15.87▼ 15.71▲ 15.82▲ 16.04▼ 14.81▲
MA20 15.95▼ 15.82▲ 16.04▼ 15.55▲ 13.48▲
MA50 15.56▲ 16.05▼ 16.05▼ 14.42▲ 13.10▲
MA100 15.88▼ 15.96▼ 15.70▲ 13.54▲ 10.16▲
MA200 15.93▼ 15.15▲ 14.74▲ 13.32▲ 10.91▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.032▼ 0.054▲ -0.023▼ -0.029▼ 0.310▲
RSI 51.430▲ 49.549▼ 48.220▼ 57.374▲ 60.895▲
STOCH 50.282     83.281▲ 71.281     64.877     86.906▲
WILL %R -55.769     -22.423▲ -27.656     -24.523▲ -15.762▲
CCI -57.486     40.052     -14.427     -218.024▼ 68.474    
Latest Filters Detected On BNTC
▼ MACD $BNTC MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $BNTC Price Crossed Below MA(13) Set Alert
MA $BNTC Price Crossed Below MA(7) Set Alert
▼ GAP $BNTC Open Gap Down %5 Set Alert
▼ GAP $BNTC Open Gap Down %3 Set Alert
▼ GAP $BNTC Open Gap Down %2 Set Alert
Benitec Biopharma Limited News
Benitec Biopharma Shares Surge 20% After FDA Grants Fast Track Status for OPMD Gene Therapy
Monday, November 03, 2025 06:35 AM
Benitec Biopharma Inc. (NASDAQ:BNTC) shares soared 20% on Monday after the biotech company announced positive interim results from its ongoing Phase 1b/2a clinical trial of BB-301 and confirmed that ...
Benitec Biopharma stock soars after FDA Fast Track designation for OPMD drug
Monday, November 03, 2025 05:21 AM
Investing.com -- Benitec Biopharma Inc. (NASDAQ:BNTC) stock rose 20% on Monday after the company announced positive interim clinical results for its BB-301 gene therapy treatment and received Fast ...
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
Monday, November 03, 2025 05:11 AM
Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has ...
BNTC historical stock data
date open high low close volume
03/11/25 13.17 16.31 13.09 15.86 409,215
31/10/25 16.00 16.68 16.00 16.36 73,759
30/10/25 16.07 16.32 15.97 16.17 42,922
29/10/25 16.04 16.67 15.35 16.17 75,468
28/10/25 15.71 16.63 15.1979 16.17 36,436
27/10/25 16.61 16.76 15.31 15.70 33,393
24/10/25 15.81 16.63 15.645 16.52 72,517
23/10/25 15.82 16.14 15.47 15.81 67,150
22/10/25 15.55 15.92 15.18 15.83 35,339
21/10/25 15.80 16.24 15.80 15.86 17,037
Quote Details
52wk Low:9.10
52wk High:17.15
Vol:409.22K
Avg Vol(3m):919.7K
1Y Chng:+65.55%
1M Chng:+19.97%
Add to Watch List
More Information
Index US Composite
Market Cap. 429.46M